即刻淋巴静脉吻合预防上肢淋巴水肿的应用探索

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:fdghghjhghjjh
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的:对即刻淋巴静脉吻合预防上肢淋巴水肿进行初步临床应用,探索术中在显微镜近红外光成像系统下应用吲哚菁绿淋巴造影,研究其淋巴管显像情况,协助淋巴管断端定位。方法:对2015年4月至6月收治的3例乳腺癌需腋窝淋巴结清扫的患者进行即刻淋巴静脉吻合。
其他文献
目的:小细胞肺癌是预后较差的侵袭性肿瘤。大规模的测序研究已经揭示在各种恶性肿瘤中潜在的疾病驱动基因,但目前仍有许多未知驱动基因,特别是在亚洲患者。我们开展这项基因组蓝图研究,通过探索中国小细胞肺癌患者的综合遗传蓝图与详细的临床病史,试图找到DNA修复途径中能影响小细胞肺癌化疗疗效的关键复发性遗传改变。
目的:IGNITE研究是一项大规模国际多中心的非干预性的诊断性研究(NCT01788163),旨在测定患有腺癌和非腺癌组织学的进展期NSCLC患者中EGFR突变发生率。本文是针对中国患者数据进行进一步的分析。
目的:本研究探索在选定人群的初治晚期NSCLC接受两周期吉西他滨/卡铂后疾病稳定(SD)的患者中,插入和维持使用吉非替尼联合化疗与单独化疗比较,是否能提高临床疗效和改善生存预后。方法:这是一项由全国14家研究中心参加的多中心随机Ⅲ期临床研究。
Objective: Long noncoding RNAs (lncRNAs) comprises a group of RNA molecules defined as transcripts longer than 200 nucleotides that lack protein coding potential.Evidence is growing that lncRNAs are i
Objective: Currently, dozens of susceptibility genes have been defined for hereditary breast cancer.Though several researches have proved the clinical utility of multiple-gene sequencing in assessment
Objective: To investigate the role of RNF31 in relation to P53 signaling and proliferation in breast cancer.Method: Western blot, q-pcr, immune precipitation, flow cytometry, cell culture, microarray
Objective: Paradigm shifts to neoadjuvant chemotherapy(NACT) for locally advanced and operable breast cancer.Hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative
Objective: Trastuzumab has been shown to medicate antibody dependent cell mediated cytotoxicity (ADCC) and inhibit HER-2.Associated Natural Killer (NK) cell with ADCC effect in metastatic breast cance
Objective: An increasing number of studies have suggested that the link between ERα methylation and triple-negative breast cancer (TNBC).We previously found the ERα methylation status in basal-like br
Objective: Proposed a new IMRT treatment planning technique with the potential of reducing low dose region of the lungs in esophageal cancer patients treated with defmitive chemoradiotherapy.